Newsroom | 41044 results
Sorted by: Latest
-
StatLab lancia CytoPath Disc e promuove la preparazione standardizzata dei citoinclusi in tutto il mondo
MCKINNEY, Texas--(BUSINESS WIRE)--StatLab Medical Products, azienda leader a livello mondiale nello sviluppo e nella produzione di strumenti, reagenti e consumabili per il laboratorio, ha annunciato oggi il lancio globale di CytoPath Disc, un’innovativa tecnologia per la preparazione di citoinclusi progettata per standardizzare e semplificare tale processo. Sviluppato come alternativa ai tradizionali metodi di citoinclusione, che trasformano materiale cellulare sospeso in un fluido in un format...
-
StatLab presenta CytoPath Disc, un avance en la preparación estandarizada de bloques celulares a nivel mundial
MCKINNEY, Texas--(BUSINESS WIRE)--StatLab Medical Products, líder mundial en desarrollo y fabricación de suministros y equipos para patología, ha anunciado hoy la presentación mundial de CytoPath Disc, una tecnología innovadora para preparar los bloques celulares, diseñada para estandarizar y simplificar todo el proceso. CytoPath Disc, cuya patente está en trámite, ha sido desarrollada como alternativa a los métodos tradicionales de preparación de los bloques celulares, que convierten las célul...
-
OSSIO Inc.’s Distribution Deal With OrthoPediatrics Corp. Brings Bio-Integrative, Metal-Free OSSIOfiber® Implants to U.S. Children’s Hospitals Nationwide
TAMPA, Fla.--(BUSINESS WIRE)--In striking an exclusive distribution agreement with OrthoPediatrics Corp. announced today, OSSIO Inc. expands access to its revolutionary orthopedic fixation technology — bio-integrative, metal-free OSSIOfiber® implants — to the approximately 400 U.S. children’s hospitals and care facilities whose orthopedic surgeons treat most pediatric patients admitted with bone fractures and skeletal deformities. "It’s not often that kids need implants for broken bones, since...
-
StatLab bringt CytoPath Disc auf den Markt und treibt damit die standardisierte Zellblockpräparation weltweit voran
MCKINNEY, Texas--(BUSINESS WIRE)--StatLab Medical Products, ein weltweit führender Entwickler und Hersteller von Verbrauchsmaterialien und Geräten für die Pathologie, gab heute die weltweite Markteinführung der CytoPath Disc bekannt, einer innovativen Technologie zur Herstellung von Zellblöcken, die darauf ausgelegt ist, die Herstellung von Zellblöcken zu standardisieren und zu vereinfachen. Die zum Patent angemeldete CytoPath Disc wurde als Alternative zu herkömmlichen Zellblockverfahren entwi...
-
StatLab lance le CytoPath Disc, une avancée mondiale dans la standardisation de la préparation des blocs cellulaires
MCKINNEY, Texas--(BUSINESS WIRE)--StatLab Medical Products, l’un des principaux développeurs et fabricants mondiaux de fournitures et d’équipements de pathologie, a annoncé aujourd’hui le lancement mondial du CytoPath Disc, une technologie innovante de préparation de blocs cellulaires conçue pour standardiser et simplifier ce processus. Développé comme une alternative aux méthodes traditionnelles de préparation de blocs cellulaires, concentrant des cellules en suspension dans un liquide en un c...
-
StatLab lanceert CytoPath Disc om gestandaardiseerde celblokpreparatie wereldwijd te bevorderen
MCKINNEY, Texas--(BUSINESS WIRE)--StatLab Medical Products, een toonaangevende internationale ontwikkelaar en fabrikant van pathologiebenodigdheden en -apparatuur, kondigde vandaag de wereldwijde lancering aan van de CytoPath Disc, een innovatieve technologie voor celblokpreparatie ontworpen om celblokpreparatie te standaardiseren en te vereenvoudigen. De CytoPath Disc met patent in aanvraag, ontwikkeld als alternatief voor traditionele celblokmethoden die geconcentreerde cellen opgelost in vlo...
-
StatLab Launches CytoPath Disc, Advancing Standardized Cell Block Preparation Worldwide
MCKINNEY, Texas--(BUSINESS WIRE)--StatLab Medical Products, a leading global developer and manufacturer of pathology supplies and equipment, today announced the global launch of the CytoPath Disc, an innovative cell block preparation technology designed to standardize and simplify cell block preparation. Developed as an alternative to traditional cell block methods, which convert concentrated cells suspended in fluid into a paraffin-embedded format for slide-based evaluation, the patent‑pending...
-
LivaNova to Announce Second-Quarter 2026 Results
LONDON--(BUSINESS WIRE)--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, will host a conference call to discuss its second-quarter 2026 results on Wed., Aug. 5, 2026, at 1 p.m. London time (8 a.m. Eastern Daylight Time). The Company will release its second-quarter 2026 results prior to the call. The audiocast will be accessible at www.livanova.com/events. Listeners should log on approximately 10 minutes in advance to ensure proper setup to receive the audiocast. To lis...
-
A New Standard of Reproducibility for Quantitative Biomarkers in Breast Imaging
NOVATO, Calif.--(BUSINESS WIRE)--QT Imaging Holdings, Inc. (Nasdaq: QTI) (“QT Imaging” or the “Company”), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, today reported the characterization of repeatability and reproducibility metrics for quantitative biomarkers generated by its QT Imaging Breast Acoustic CTTM Scanner platform.As healthcare increasingly adopts quantitative imaging biomarkers to monitor disease, as...
-
Forescout Launches New Post-Quantum Cryptography (PQC) Dashboards to Analyze Quantum-Exposure Risk Across IT, OT, IoT, and IoMT
SAN JOSE, Calif.--(BUSINESS WIRE)--Forescout Technologies Inc., a global cybersecurity leader, today announced the launch of its Post-Quantum Cryptography (PQC) Readiness and Encryption Hygiene Dashboards. The new dashboards are designed to help organizations identify, prioritize, and manage quantum risk across information technology (IT), operational technology (OT), Internet of Things (IoT), and medical devices (IoMT) environments. As organizations face new pressures from regulators, auditors...